StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
COMPASS Pathways plc
NasdaqGS:CMPS
Sector
Industries
Location
Market Cap
USD 408.87 M
Share Price
USD 4.37
Avg Daily Volume
2,362,033
Change (1 day)
-5.41%
Change (1 year)
-37.03%
Change (YTD)
15.61%
COMPASS Pathways plc EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD -171.93 M
COMPASS Pathways plc EBITDA is USD -171.93 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 33.18% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
COMPASS Pathways plc EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -129.10 M, a 24.72% change year over year.
-
COMPASS Pathways plc EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -103.51 M, a 23.48% change year over year.
-
COMPASS Pathways plc EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -83.83 M, a 62.96% change year over year.
-
COMPASS Pathways plc EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -51.44 M.
Competitors
Boston Scientific Corporation
USD 106.21
BSX
-1.55
-1.44%
Siemens Healthineers AG
USD 56.26
SHL.DE
+1.52
2.77%
Cencora, Inc.
USD 290.45
COR
-2.99
-1.02%
Edwards Lifesciences Corporation
USD 75.80
EW
-1.11
-1.44%
GE HealthCare Technologies Inc.
USD 76.77
GEHC
-0.48
-0.62%
DexCom, Inc.
USD 86.74
DXCM
+0.31
0.36%
IQVIA Holdings Inc.
USD 200.82
IQV
+6.58
3.39%
Laboratory Corporation of America Holdings
USD 267.69
LH
+17.18
6.86%
Natera, Inc.
USD 141.06
NTRA
+3.25
2.35%
Somnigroup International Inc
USD 73.88
SGI
-1.12
-1.49%
Hologic, Inc.
USD 66.10
HOLX
+0.15
0.23%
Baxter International Inc.
USD 28.77
BAX
+0.21
0.73%
Torrent Pharmaceuticals Limited
USD 41.46
TORNTPHARM.NS
+0.76
1.87%
ICON Public Limited Company
USD 195.01
ICLR
+27.12
16.15%
Neurocrine Biosciences, Inc.
USD 131.64
NBIX
-2.02
-1.51%
Fisher & Paykel Healthcare Corporation Limited
USD 21.90
FPH.NZ
-0.11
-0.51%
Zydus Lifesciences Limited
USD 11.28
ZYDUSLIFE.NS
+0.05
0.46%
Ascendis Pharma A/S
USD 168.31
ASND
-1.83
-1.08%
Exact Sciences Corporation
USD 48.77
EXAS
+0.36
0.74%
Penumbra, Inc.
USD 230.18
PEN
-3.21
-1.38%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
Boston Scientific Corporation
USD 106.21
BSX
-1.55
-1.44%
Siemens Healthineers AG
USD 56.26
SHL.DE
+1.52
2.77%
Cencora, Inc.
USD 290.45
COR
-2.99
-1.02%
Edwards Lifesciences Corporation
USD 75.80
EW
-1.11
-1.44%
GE HealthCare Technologies Inc.
USD 76.77
GEHC
-0.48
-0.62%
DexCom, Inc.
USD 86.74
DXCM
+0.31
0.36%
IQVIA Holdings Inc.
USD 200.82
IQV
+6.58
3.39%
Laboratory Corporation of America Holdings
USD 267.69
LH
+17.18
6.86%
Natera, Inc.
USD 141.06
NTRA
+3.25
2.35%
Somnigroup International Inc
USD 73.88
SGI
-1.12
-1.49%
Hologic, Inc.
USD 66.10
HOLX
+0.15
0.23%
Baxter International Inc.
USD 28.77
BAX
+0.21
0.73%
Torrent Pharmaceuticals Limited
USD 41.46
TORNTPHARM.NS
+0.76
1.87%
ICON Public Limited Company
USD 195.01
ICLR
+27.12
16.15%
Neurocrine Biosciences, Inc.
USD 131.64
NBIX
-2.02
-1.51%
Fisher & Paykel Healthcare Corporation Limited
USD 21.90
FPH.NZ
-0.11
-0.51%
Zydus Lifesciences Limited
USD 11.28
ZYDUSLIFE.NS
+0.05
0.46%
Ascendis Pharma A/S
USD 168.31
ASND
-1.83
-1.08%
Exact Sciences Corporation
USD 48.77
EXAS
+0.36
0.74%
Penumbra, Inc.
USD 230.18
PEN
-3.21
-1.38%